68 Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making and long-term benefits - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Conference Papers Year : 2020

68 Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making and long-term benefits

Domains

Cancer
Fichier principal
Vignette du fichier
Rousseau2020Eq13.pdf (199.34 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-03495609 , version 1 (20-12-2021)

Identifiers

Cite

Caroline Rousseau, Ludovic Ferrer, Maelle Le Thiec, Vincent Fleury, Mathieu Frindel, et al.. 68 Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making and long-term benefits. 33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), European-Association-of-Nuclear-Medicine (EANM), Oct 2020, Virtuel, France. pp.S323, ⟨10.1002/pros.23869⟩. ⟨inserm-03495609⟩
7 View
50 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More